Specialty Pharmacy

Clarithromycin (Biaxin) may increase the risk of heart problems and death among patients with cardiovascular disease.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The new purchasing efforts may help increase biosimilar uptake and lower drug costs.

Teens in the criminal justice system have a higher risk of contracting HIV.

Health and Human Services Secretary Alex Azar could take action to help millions of Americans gain access to necessary drugs.

Many neuroendocrine cancers may be misdiagnosed without molecular pathway mapping.

There are significant unmet clinical needs among patients with amyotrophic lateral sclerosis.

Top news of the day from across the health care landscape.

Half of millennial-aged men and women said they have never been tested for HIV outside of blood donation.

New antiretroviral combination will be accessible to patients with HIV/AIDS in countries with limited resources.

Adolescent and young adult cancer survivors have a higher rate of heart disease, infertility, and cancer recurrence.

The Cx26 protein may be involved with promoting aggressive breast cancer.

An experimental antiviral drug shows promise fighting multiple infectious diseases.

Matt Gillin, Chief Executive Officer, Relay Network, speaks about takeaways specialty pharmacies can learn from other businesses in terms of customer communications, adoption, and behavior change.

Top news of the day from across the health care landscape.

Amazon's acquisition of Whole Foods could lead to pharmacies closing their doors.

Federal judge finds that sofosbuvir (Sovaldi) and ledipasvir/sofosbuvir (Harvoni) do not infringe on Merck patents.

If passed, a bill that addresses the prevention and treatment of chronic diseases may ensure better care for patients.

Deep transcranial stimulation could provide more relief from fatigue among multiple sclerosis patients compared with other treatments.

Researchers discover underlying reason why patients with Huntington's disease have a significantly lower risk of cancer.

Top news of the day from across the health care landscape.

Patients who achieved hepatitis C virus eradication experienced a reduction in hepatic steatosis and fibrosis.

Combining oncolytic viruses and immunotherapies may fight cancer more effectively.

Treatment with durvalumab (Imfinzi) reduces the risk of disease progression among patients with non-small cell lung cancer.

Enzalutamide (Xtandi) demonstrates a significant reduction in metastasis or death from castration-resistant prostate cancer

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, speaks to the difficulties that face manufacturers who are launching a novel specialty product.

PRDM14 is involved with embryonic development and may lead to germ cell tumors.

Top news of the day from across the health care landscape.

Many key specialty pharmacy issues discussed at the Payer/Managed Care Strategies for Specialty Medications Annual Symposium.

Health care professionals should provide resources that help patients with HIV practice self-care.